John Tucker

John H.
Tucker is President, Chief Executive Officer & Director at Xylocor Therapeutics, Inc. since 2026.
Mr. Tucker is Director at Eleusis Holdings Ltd. since 2021.
Formerly, Mr. Tucker was President, Chief Executive Officer & Director at scPharmaceuticals, Inc. from 2017 to 2025.
Mr. Tucker was President, Chief Executive Officer & Treasurer at ASC Liquidation Corp.
from 2016 to 2017.
Mr. Tucker was Chief Executive Officer & Director at Alcresta Therapeutics, Inc. from 2014 to 2016.
Mr. Tucker was Chief Executive Officer-North American Business at Nelson Bach Usa Ltd. from 2013 to 2014.
Mr. Tucker was Director at Eleusis Holdings Ltd. from 2021 to 2022.
Mr. Tucker was Chief Commercial Officer & Senior Vice President at Incline Therapeutics, Inc. from 2012 to 2013.
Mr. Tucker was Senior Vice President-Commercial Operations at AMAG Pharmaceuticals, Inc. in 2012.
Mr. Tucker was President-US Operations at Basilea Pharmaceuticals Ltd. from 2007 to 2011.
Mr. Tucker was Executive Vice President-Sales & Marketing at Indevus Pharmaceuticals, Inc. from 2002 to 2007.
Education includes undergraduate studies at Plymouth State University and an MBA from Southern New Hampshire University.